Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Jan A, Stratmann"'
Autor:
Lisa Falchetto, Bernd Bender, Ian Erhard, Kim N. Zeiner, Jan A. Stratmann, Florestan J. Koll, Sebastian Wagner, Marcel Reiser, Khayal Gasimli, Angelika Stehle, Martin Voss, Olivier Ballo, Jörg Janne Vehreschild, Daniel Maier
Publikováno v:
BMC Research Notes, Vol 17, Iss 1, Pp 1-6 (2024)
Abstract Objective The concept of lines of therapy (LOT) in cancer treatment is often considered for decision making in tumor boards and clinical management, but lacks a common definition across medical specialties. The complexity and heterogeneity o
Externí odkaz:
https://doaj.org/article/2ddb10a220324f82a22c2648f4c609fc
Autor:
Andrea Wolf, Jan A. Stratmann, Shabnam Shaid, Nicolas Niklas, Alan Calleja, Harveen Ubhi, Robin Munro, Daniela Waldenberger, Robert Carroll, Melinda J. Daumont, John R. Penrod, Laure Lacoin, Gernot Rohde
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Immune checkpoint inhibitors (ICIs) have improved outcomes for patients with advanced non-small cell lung cancer (NSCLC) versus chemotherapy in clinical trials. In Germany, ICIs have been used clinically since 2015 for patients wi
Externí odkaz:
https://doaj.org/article/5aee040f57354f198ee5a2adc10dbbcc
Autor:
Friederike C. Althoff, Lisa V. Schäfer, Fabian Acker, Lukas Aguinarte, Sophie Heinzen, Maximilian Rost, Akin Atmaca, Vivian Rosery, Jürgen Alt, Cornelius F. Waller, Niels Reinmuth, Gernot Rohde, Felix C. Saalfeld, Aaron Becker von Rose, Miriam Möller, Nikolaj Frost, Martin Sebastian, Jan A. Stratmann
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionSmall cell lung cancer (SCLC) is a rapidly growing malignancy with early distant metastases. Up to 70% will develop brain metastases, and the poor prognosis of these patients has not changed considerably. The potential of checkpoint inhib
Externí odkaz:
https://doaj.org/article/3f16ad1b888741e5ae6ae8361e6b7cfa
Autor:
Jan A. Stratmann, Radha Timalsina, Akin Atmaca, Vivian Rosery, Nikolaj Frost, Jürgen Alt, Cornelius F. Waller, Niels Reinmuth, Gernot Rohde, Felix C. Saalfeld, Aaron Becker von Rose, Fabian Acker, Lukas Aspacher, Miriam Möller, Martin Sebastian
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Objectives: Small-cell lung cancer (SCLC) is a lung malignancy with high relapse rates and poor survival outcomes. Treatment-resistant disease relapse occurs frequently and effective salvage therapies are urgently needed. Materials and Methods: We ai
Externí odkaz:
https://doaj.org/article/3241382465814be1b90a998fcc16090e
Autor:
Sebastian E. Koschade, Jan A. Stratmann, Pia S. Zeiner, Fabian Finkelmeier, Jörg Chromik, Björn Steffen, Hubert Serve, Christian H. Brandts, Olivier Ballo
Publikováno v:
Annals of Hematology. 102:1045-1052
Cranial imaging (CI) is a widely used diagnostic procedure, especially in acute myeloid leukemia (AML) patients with suspected bleeding or infection. However, common clinical decision rules to guide CI do not apply to AML patients and the diagnostic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e68129071f10466f270e79b0a95863a
https://doi.org/10.1007/s00277-023-05178-6
https://doi.org/10.1007/s00277-023-05178-6
Autor:
Sebastian E. Koschade, Jan A. Stratmann, Björn Steffen, Shabnam Shaid, Fabian Finkelmeier, Hubert Serve, Wolfgang Miesbach, Christian H. Brandts, Olivier Ballo
Publikováno v:
European Journal of Haematology. 110:426-434
Venous thromboembolic (VTE) events are emerging as frequent complications in acute myeloid leukemia (AML); however, there is insufficient data regarding epidemiology, risk factors and impact on outcomes. The optimal approach to balance risks of throm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b4474bb9983b210d55bd0484b8078d2
https://doi.org/10.1111/ejh.13920
https://doi.org/10.1111/ejh.13920
Autor:
Kathrin Kobus, Bianca Bohmann, Manuel Wilbring, Marvin Kapalla, Hans-Henning Eckstein, Florian Bassermann, Jan A. Stratmann, Adam Wahida, Christian Reeps, Benedikt J. Schwaiger, Albert Busch, Aaron Becker von Rose
Publikováno v:
Vasa. 52:38-45
Summary: Background: Multi-morbidity poses a substantial challenge for health care in an aging population. Recent studies did not provide evidence for general side effects of anti-cancer therapy regarding the growth rate of coincident abdominal aorti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90d49d701fce3670fc1e48a7a349ae9d
https://doi.org/10.1024/0301-1526/a001038
https://doi.org/10.1024/0301-1526/a001038
Autor:
Jan A Stratmann, Raphael Lacko, Olivier Ballo, Shabnam Shaid, Wolfgang Gleiber, Maria J G T Vehreschild, Thomas Wichelhaus, Claudia Reinheimer, Stephan Göttig, Volkhard A J Kempf, Peter Kleine, Susanne Stera, Christian Brandts, Martin Sebastian, Sebastian Koschade
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0242544 (2020)
ObjectivesMultidrug-resistant organisms (MDRO) are considered an emerging threat worldwide. Data covering the clinical impact of MDRO colonization in patients with solid malignancies, however, is widely missing. We sought to determine the impact of M
Externí odkaz:
https://doaj.org/article/bffd8075374f4d809c14b4e40601ffda
Autor:
Sebastian E. Koschade, Kevin Klann, Shabnam Shaid, Binje Vick, Jan A. Stratmann, Marlyn Thölken, Laura M. Meyer, The Duy Nguyen, Julia Campe, Laura M. Moser, Susanna Hock, Fatima Baker, Christian T. Meyer, Frank Wempe, Hubert Serve, Evelyn Ullrich, Irmela Jeremias, Christian Münch, Christian H. Brandts
Publikováno v:
Leukemia 36, 2396-2407 (2022)
Internal tandem duplications (ITD) in the receptor tyrosine kinase FLT3 occur in 25 % of acute myeloid leukemia (AML) patients, drive leukemia progression and confer a poor prognosis. Primary resistance to FLT3 kinase inhibitors (FLT3i) quizartinib,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00079da74ab580da84cb0d64ca028906
https://doi.org/10.1038/s41375-022-01678-y
https://doi.org/10.1038/s41375-022-01678-y
Autor:
Jan Alexander Stratmann, Stefan Gundermann, Christof Geisen, Alexandra Dukat, Wolfgang Miesbach
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 13, Iss 1 (2019)
Background: Autologous stem cell transplantation is considered a standard of care treatment in eligible patients with multiple myeloma, but puts the patient at high risk for infections and bleeding complications. Acquired von-Willebrand's disease (AV
Externí odkaz:
https://doaj.org/article/3151a4aec1d74a8d9c81701554053933